• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Clin Med . Complex Immunometabolic Profiling Reveals the Activation of Cellular Immunity and Biliary Lesions in Patients with Severe COVID-19

tetano

Editor, Senior Moderator
J Clin Med


. 2020 Sep 17;9(9):E3000.
doi: 10.3390/jcm9093000.
Complex Immunometabolic Profiling Reveals the Activation of Cellular Immunity and Biliary Lesions in Patients with Severe COVID-19


Adam Klocperk[SUP] 1 [/SUP], Marketa Bloomfield[SUP] 1 2 [/SUP], Zuzana Parackova[SUP] 1 [/SUP], Irena Zentsova[SUP] 1 [/SUP], Petra Vrabcova[SUP] 1 [/SUP], Jan Balko[SUP] 3 [/SUP], Grigorij Meseznikov[SUP] 4 [/SUP], Luis Fernando Casas Mendez[SUP] 5 [/SUP], Alzbeta Grandcourtova[SUP] 5 [/SUP], Jan Sipek[SUP] 6 [/SUP], Martin Tulach[SUP] 4 [/SUP], Josef Zamecnik[SUP] 3 [/SUP], Tomas Vymazal[SUP] 6 [/SUP], Anna Sediva[SUP] 1 [/SUP]



Affiliations

Abstract

This study aimed to assess the key laboratory features displayed by coronavirus disease 2019 (COVID-19) inpatients that are associated with mild, moderate, severe, and fatal courses of the disease, and through a longitudinal follow-up, to understand the dynamics of the COVID-19 pathophysiology. All severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-positive patients admitted to the University Hospital in Motol between March and June 2020 were included in this study. A severe course of COVID-19 was associated with an elevation of proinflammatory markers; an efflux of immature granulocytes into peripheral blood; the activation of CD8 T cells, which infiltrated the lungs; transient liver disease. In particular, the elevation of serum gamma-glutamyl transferase (GGT) and histological signs of cholestasis were highly specific for patients with a severe form of the disease. In contrast, patients with a fatal course of COVID-19 failed to upregulate markers of inflammation, showed discoordination of the immune response, and progressed toward acute kidney failure. COVID-19 is a disease with a multi-organ affinity that is characterized by the activation of innate and cellular adaptive immunity. Biliary lesions with an elevation of GGT and the organ infiltration of interleukin 6 (IL-6)-producing cells are the defining characteristics for patients with the fulminant disease.

Keywords: COVID-19; GGT; IL-6; SARS-CoV-2; T cells; acute kidney injury; biliary lesion; hepatopathy; immunity; liver disease.
 
Back
Top Bottom